SCHEMBL29412622

SCHEMBL29412622

NNC(=O)C=Cc1ccccc1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFKB1 P19838 2/20 0.63
▸ JUN P05412 1/20 0.63
▸ NFE2L2 Q16236 1/20 0.63
▸ CA1 P00915 1/20 0.61
▸ CA2 P00918 1/20 0.61
▸ CA4 P22748 1/20 0.61
▸ MAPT P10636 4/20 0.59
▸ LMNA P02545 1/20 0.59
▸ BCHE P06276 1/20 0.56
▸ GUSB P08236 1/20 0.56
▸ CHRNA7 P36544 3/20 0.53
▸ MAPK1 P28482 2/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ ALPL P05186 1/20 0.49
▸ ALPI P09923 1/20 0.49
▸ ALPG P10696 1/20 0.49
▸ NPC1 O15118 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4254014 1.00 NFKB1 (0.63) NFKB1JUNNFE2L2CA1CA2
SCHEMBL12425714 1.00 NFKB1 (0.63) NFKB1JUNNFE2L2CA1CA2
SCHEMBL12426301 0.83 HDAC8 (0.66) NFKB1JUNNFE2L2CA1CA2
SCHEMBL14244199 0.83 HDAC8 (0.66) NFKB1JUNNFE2L2CA1CA2
SCHEMBL17305570 0.81 MAPT (0.65) NFKB1JUNNFE2L2CA1CA2
SCHEMBL9444501 0.81 MAPT (0.65) NFKB1JUNNFE2L2CA1CA2
SCHEMBL1562801 0.81 MAPT (0.65) NFKB1JUNNFE2L2CA1CA2
SCHEMBL765999 0.79 NFKB1 (0.70) NFKB1JUNNFE2L2CA1CA2
SCHEMBL3508748 0.79 NFKB1 (0.70) NFKB1JUNNFE2L2CA1CA2
SCHEMBL8687395 0.79 NFKB1 (0.70) NFKB1JUNNFE2L2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4204401-A1 COMPOUNDS FOR AND METHODS OF TREATING DISEASES Alterity Therapeutics Limited (AU) 2023-07-05 — — EP disclosed
WO-2022040747-A1 COMPOUNDS FOR AND METHODS OF TREATING DISEASES Alterity Therapeutics Limited (AU) 2022-03-03 — — WO disclosed
Send feedback